SII plans to seek restricted emergency use permission of the vaccine in India. The DCGI has granted permission to the Serum Institute of India (SII) to manufacture the Sputnik COVID-19 vaccine in India for examination, test and analysis with certain conditions, official sources said on Friday. The Pune-based firm has collaborated with Gamaleya Research Institute of Epidemiology and Microbiology, Moscow in Russia for developing Sputnik V at its licensed Hadapsar facility. “The DCGI has granted permission to the Serum Institute to manufacture the Sputnik COVID-19 vaccine in India for examination, test and analysis at its licensed Hadapsar facility with certain conditions,” an official source said.
Coronavirus | Decision on lockdown extension in Tamil Nadu to be announced on Saturday
Updated:
Updated:
Chief Secretary V. Irai Anbu, Director-General of Police J.K. Tripathy and senior officials participated.
Share Article
AAA
On Friday, Chief Minister M.K. Stalin chaired a meeting of officials to discuss the COVID-19 scenario and the lockdown restrictions across the State. | Photo Credit:
DIPR
Chief Secretary V. Irai Anbu, Director-General of Police J.K. Tripathy and senior officials participated. The Tamil Nadu government would on Saturday announce whether the ongoing intense COVID-19 lockdown in the State would be extended beyond the morning of June 7 or not.
Updated:
Virus could come back in case people don’t act responsibly: Dr. Paul
Share Article
AAA
Virus could come back in case people don’t act responsibly: Dr. Paul
The Union government was still in negotiation and no final decision had been taken on indemnity to either foreign or local COVID-19 vaccine manufacturers, NITI Aayog member (health) Dr. V.K. Paul said at a Health Ministry press conference on Friday.
India had overtaken the U.S. in providing at least one dose of vaccine. “As of Thursday night, India has administered 17.2 crore doses, while the U.S. has administered 16.9 crore doses,” he said.